{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:46:06Z","timestamp":1793670366969,"version":"4.5.1"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The outbreaks of respiratory pathogens like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus (IV) have heightened the demand for highly effective vaccines that provide strong and durable immunity in human populations. However, immune responses to vaccination vary significantly among individuals and populations. Recent studies have demonstrated that the gut microbiota play an essential role in regulating respiratory pathogens vaccination-induced immune responses through the systemic effects of gut-lung axis on distant organs, the lungs. In this review, we first synthesize the changes in gut microbiota composition and immune responses that occur during respiratory pathogen infections and vaccination. Then, we discuss the underlying immunological mechanisms of bidirectional immunomodulatory effects between gut microbiota and vaccines. Finally, we explore the strategies for designing next-generation vaccines against respiratory pathogens in term of gut microbiota-mediated immunological pathway.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1618921","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:22:27Z","timestamp":1748928147000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunomodulatory effects of gut microbiota on vaccine efficacy against respiratory pathogens"],"prefix":"10.3389","volume":"16","author":[{"given":"Li","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41577-021-00554-7","article-title":"Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms","volume":"22","author":"Lynn","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2233146","article-title":"A comprehensive perspective on the interaction between gut microbiota and covid-19 vaccines","volume":"15","author":"Hong","year":"2023","journal-title":"Gut Microbes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01305","article-title":"Role of the microbiota in the modulation of vaccine immune responses","volume":"10","author":"Ciabattini","year":"2019","journal-title":"Front Microbiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41541-023-00627-9","article-title":"The immunological interplay between vaccination and the intestinal microbiota","volume":"8","author":"Zimmermann","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326563","article-title":"Gut microbiota composition is associated with sars-cov-2 vaccine immunogenicity and adverse events","volume":"71","author":"Ng","year":"2022","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062747","article-title":"Rapamycin and inulin for third-dose vaccine response stimulation (Rivastim): inulin - study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve sars-cov-2 vaccine response in kidney transplant recipients","volume":"12","author":"Singer","year":"2022","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00185-9","article-title":"The early-life gut microbiome and vaccine efficacy","volume":"3","author":"Jordan","year":"2022","journal-title":"Lancet Microbe"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.889945","article-title":"Microbiota and the response to vaccines against respiratory virus","volume":"13","author":"Goncalves","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309728","article-title":"The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia","volume":"65","author":"Schuijt","year":"2016","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41385-020-00361-8","article-title":"The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes","volume":"14","author":"Sencio","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2536","article-title":"Shifting the balance: antibiotic effects on host-microbiota mutualism","volume":"9","author":"Willing","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00698-4","article-title":"Gut microbiota in covid-19: key microbial changes, potential mechanisms and clinical applications","volume":"20","author":"Zhang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147724","article-title":"The gut-lung axis in influenza A: the role of gut microbiota in immune balance","volume":"14","author":"Ou","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.chom.2024.01.002","article-title":"Intestinal microbiota programming of alveolar macrophages influences severity of respiratory viral infection","volume":"32","author":"Ngo","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging pathogenic links between microbiota and the gut-lung axis","volume":"15","author":"Budden","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.270","article-title":"Gut-X axis","volume":"4","author":"Lin","year":"2025","journal-title":"Imeta"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202206-1066TR","article-title":"The bidirectional gut-lung axis in chronic obstructive pulmonary disease","volume":"207","author":"Wang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41579-024-01048-8","article-title":"The gut-airway microbiome axis in health and respiratory diseases","volume":"22","author":"Ozcam","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.08.008","article-title":"Childhood respiratory viral infections and the microbiome","volume":"152","author":"Kloepfer","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa709","article-title":"Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1n1 influenza","volume":"71","author":"Gu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1301312","article-title":"Perturbations in gut and respiratory microbiota in covid-19 and influenza patients: A systematic review and meta-analysis","volume":"11","author":"Chu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1887722","article-title":"Integrated gut virome and bacteriome dynamics in covid-19 patients","volume":"13","author":"Cao","year":"2021","journal-title":"Gut Microbes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111896","article-title":"Gegen qinlian decoction alleviate influenza virus infectious pneumonia through intestinal flora","volume":"141","author":"Deng","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-023-00044-6","article-title":"Influence of microbiota on vaccine effectiveness: \u201cIs the microbiota the key to vaccine-induced responses","volume":"61","author":"Hong","year":"2023","journal-title":"J Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00726","article-title":"Gut dysbiosis thwarts the efficacy of vaccine against mycobacterium tuberculosis","volume":"11","author":"Nadeem","year":"2020","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado9455","article-title":"Gut iga functionally interacts with systemic igg to enhance antipneumococcal vaccine responses","volume":"11","author":"Gutzeit","year":"2025","journal-title":". Sci Adv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/vaccines12040365","article-title":"Association between gut microbiota composition and long-term vaccine immunogenicity following three doses of coronavac","volume":"12","author":"Zhang","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411703","article-title":"Baseline gut microbiome signatures correlate with immunogenicity of sars-cov-2 mrna vaccines","volume":"24","author":"Daddi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12967-024-05637-2","article-title":"The gut microbiota modifies antibody durability and booster responses after sars-cov-2 vaccination","volume":"22","author":"Seong","year":"2024","journal-title":"J Transl Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-023-01445-0","article-title":"Gut microbiota as a potential key to modulating humoral immunogenicity of new platform covid-19 vaccines","volume":"8","author":"Seong","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13059-021-02482-0","article-title":"The influence of the gut microbiome on bcg-induced trained immunity","volume":"22","author":"Strazar","year":"2021","journal-title":"Genome Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12879-024-09189-0","article-title":"Gut Microbial Features May Influence Antiviral Igg Levels after Vaccination against Viral Respiratory Infectious Diseases: The Evidence from Two-Sample Bidirectional Mendelian Randomization","volume":"24","author":"Tu","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.chom.2018.04.009","article-title":"Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice","volume":"23","author":"Lynn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00654-23","article-title":"Comparison of mouse models of microbial experience reveals differences in microbial diversity and response to vaccination","volume":"9","author":"Sanders","year":"2024","journal-title":"mSphere"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.chom.2021.10.001","article-title":"Mice with diverse microbial exposure histories as a model for preclinical vaccine testing","volume":"29","author":"Fiege","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01354-4","article-title":"Parenteral bcg vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis","volume":"23","author":"Jeyanathan","year":"2022","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01693-21","article-title":"Mouse subcutaneous bcg vaccination and mycobacterium tuberculosis infection alter the lung and gut microbiota","volume":"10","author":"Silva","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029355","article-title":"Do the microbiota influence vaccines and protective immunity to pathogens? If so, is there potential for efficacious microbiota-based vaccines","volume":"10","author":"Littman","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17241","article-title":"The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions","volume":"292","author":"Rossouw","year":"2025","journal-title":"FEBS J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"126121","DOI":"10.1016\/j.vaccine.2024.07.022","article-title":"Covid-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study","volume":"42","author":"Hoeve","year":"2024","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/jci133935","article-title":"Bcg vaccination in humans Inhibits Systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41577-019-0227-3","article-title":"Antibiotics can impede flu vaccines","volume":"19","author":"Bordon","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines5040050","article-title":"Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes","volume":"5","author":"Vitetta","year":"2017","journal-title":"Vaccines"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ph8020351","article-title":"Effects of a formula containing two types of prebiotics, bifidogenic growth stimulator and galacto-oligosaccharide, and fermented milk products on intestinal microbiota and antibody response to influenza vaccine in elderly patients: A randomized controlled trial","volume":"8","author":"Nagafuchi","year":"2015","journal-title":"Pharmaceuticals (Basel)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.765528","article-title":"Potential association between dietary fibre and humoral response to the seasonal influenza vaccine","volume":"12","author":"Cait","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2019.02.006","article-title":"Innate sensors that regulate vaccine responses","volume":"59","author":"Georg","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6975","article-title":"Immunology taught by vaccines","volume":"366","author":"Pulendran","year":"2019","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.08.009","article-title":"Tlr5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination","volume":"41","author":"Oh","year":"2014","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.086","article-title":"Development of vax128, a recombinant hemagglutinin (Ha) influenza-flagellin fusion vaccine with improved safety and immune response","volume":"30","author":"Taylor","year":"2012","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002257","article-title":"Efficacious recombinant influenza vaccines produced by high yield bacterial expression: A solution to global pandemic and seasonal needs","volume":"3","author":"Nixon","year":"2008","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"125836","DOI":"10.1016\/j.vaccine.2024.03.063","article-title":"Safety, reactogenicity and immunogenicity of an intranasal seasonal influenza vaccine adjuvanted with gram-positive matrix (Gem) particles (Flugem): A randomized, double-blind, controlled, ascending dose study in healthy adults and elderly","volume":"42","author":"van der Plas","year":"2024","journal-title":"Vaccine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1432989","article-title":"A gram-positive enhancer matrix particles vaccine displaying swine influenza virus hemagglutinin protects mice against lethal H1n1 viral challenge","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1082273","article-title":"The adjuvant effect of bacterium-like particles depends on the route of administration","volume":"14","author":"Sudo","year":"2023","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9168-2","article-title":"Intranasal delivery of influenza subunit vaccine formulated with gem particles as an adjuvant","volume":"12","author":"Saluja","year":"2010","journal-title":"AAPS J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2165\/11206820-000000000-00000","article-title":"As04-adjuvanted human papillomavirus (Hpv) types 16 and 18 vaccine (Cervarix\u00ae): A review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic hpv types","volume":"71","author":"McKeage K","year":"2011","journal-title":"Drugs"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126577","article-title":"Immune profile diversity is achieved with synthetic tlr4 agonists combined with the rg1-vlp vaccine in mice","volume":"44","author":"Matthews","year":"2025","journal-title":"Vaccine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40259-023-00627-0","article-title":"Outer membrane vesicle vaccine platforms","volume":"38","author":"Micoli","year":"2023","journal-title":"BioDrugs"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101546","article-title":"Immunogenicity and pre-clinical efficacy of an omv-based sars-cov-2 vaccine","volume":"11","author":"Grandi","year":"2023","journal-title":"Vaccines"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106203242503","article-title":"The efficacy in navajo infants of a conjugate vaccine consisting of haemophilus influenzae type B polysaccharide and neisseria meningitidis outer-membrane protein complex","volume":"324","author":"Santosham","year":"1991","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124416","article-title":"Omv vaccines and the role of tlr agonists in immune response","volume":"21","author":"Mancini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524290113","article-title":"Type vi secretion system sheaths as nanoparticles for antigen display","volume":"113","author":"Del Tordello","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.07.001","article-title":"Gut microbial metabolites fuel host antibody responses","volume":"20","author":"Kim","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00656-23","article-title":"Short-chain fatty acids alleviate vancomycin-caused humoral immunity attenuation in rabies-vaccinated mice by promoting the generation of plasma cells via akt-mtor pathway","volume":"97","author":"Wu","year":"2023","journal-title":"J Virol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100752","article-title":"Correlation of gut microbiota and metabolic functions with the antibody response to the bbibp-corv vaccine","volume":"3","author":"Tang","year":"2022","journal-title":"Cell Rep Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-024-01057-x","article-title":"How bile acids and the microbiota interact to shape host immunity","volume":"24","author":"Lee","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.642546","article-title":"Bile acids impair vaccine response in children with biliary atresia","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.10.021","article-title":"Virus-specific cd4(+) memory-phenotype T cells are abundant in unexposed adults","volume":"38","author":"Su","year":"2013","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.chom.2023.10.007","article-title":"Cross-regulation of antibody responses against the sars-cov-2 spike protein and commensal microbiota via molecular mimicry","volume":"31","author":"Bondareva","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2117503","article-title":"Preexisting antibodies targeting sars-cov-2 S2 cross-react with commensal gut bacteria and impact covid-19 vaccine induced immunity","volume":"14","author":"Jia","year":"2022","journal-title":"Gut Microbes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.09.004","article-title":"On developmental programming of the immune system","volume":"44","author":"Hong","year":"2023","journal-title":"Trends Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0367-2","article-title":"Host-microbiota interactions in immune-mediated diseases","volume":"18","author":"Ruff","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00874-w","article-title":"Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease","volume":"23","author":"Donald","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cell.2024.11.020","article-title":"A gut commensal protozoan Determines respiratory disease outcomes by shaping pulmonary immunity","volume":"188","author":"Burrows","year":"2025","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108387","article-title":"Bcg vaccination induces long-term functional reprogramming of human neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00900","article-title":"Nasal iga provides protection against human influenza challenge in volunteers with low serum influenza antibody titre","volume":"8","author":"Gould","year":"2017","journal-title":"Front Microbiol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2023.21870","article-title":"Fda will evaluate first self-administered flumist vaccine","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.13.1677","article-title":"Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts","volume":"284","author":"Hurwitz ES","year":"2000","journal-title":"JAMA"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101331","article-title":"Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis","volume":"46","author":"Minozzi","year":"2022","journal-title":"eClinicalMedicine"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(24)00351-7","article-title":"Safety and immunogenicity of the intranasal H3n2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone high-dose quadrivalent) in adults aged 65\u201385 years in the USA: A multicentre, randomised, double-blind, double-dummy, phase 1b trial","volume":"24","author":"Eiden","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1038\/s41467-023-43842-7","article-title":"Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine","volume":"14","author":"Thwaites","year":"2023","journal-title":"Nat Commun"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal immunity in covid-19: A neglected but critical aspect of sars-cov-2 infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/v14020187","article-title":"Mucosal vaccines, sterilizing immunity, and the future of sars-cov-2 virulence","volume":"14","author":"Focosi","year":"2022","journal-title":"Viruses"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.01.003","article-title":"Upper respiratory tract mucosal immunity for sars-cov-2 vaccines","volume":"29","author":"Fraser","year":"2023","journal-title":"Trends Mol Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal iga protection against sars-cov-2 omicron infection","volume":"387","author":"Havervall","year":"2022","journal-title":"N Engl J Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj9285","article-title":"Mucosal and systemic immune correlates of viral control after sars-cov-2 infection challenge in seronegative adults","volume":"9","author":"Wagstaffe","year":"2024","journal-title":"Sci Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06951-3","article-title":"Mucosal boosting enhances vaccine protection against sars-cov-2 in macaques","volume":"626","author":"McMahan","year":"2024","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.073","article-title":"Preclinical immunogenicity and protective efficacy of an oral helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant","volume":"36","author":"Holmgren","year":"2018","journal-title":"Vaccine"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00538-10","article-title":"Characterization of a mutant escherichia coli heat-labile toxin, lt(R192g\/L211a), as a safe and effective oral adjuvant","volume":"18","author":"Norton","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06809-8","article-title":"Inhaled sars-cov-2 vaccine for single-dose dry powder aerosol immunization","volume":"624","author":"Ye","year":"2023","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/vaccines7040150","article-title":"Adjuvant strategies for lactic acid bacterial mucosal vaccines","volume":"7","author":"Vilander","year":"","journal-title":"Vaccines (Basel)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712274","article-title":"Recombinant mycobacterium paragordonae expressing sars-cov-2 receptor-binding domain as a vaccine candidate against sars-cov-2 infections","volume":"12","author":"Kim","year":"2021","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.08.232","article-title":"Mucosal iga response elicited by intranasal immunization of lactobacillus plantarum expressing surface-displayed rbd protein of sars-cov-2","volume":"190","author":"Li","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biotech11010003","article-title":"Hacking commensal bacteria to consolidate the adaptive mucosal immune response in the gut-lung axis: future possibilities for sars-cov-2 protection","volume":"11","author":"Pereira","year":"2022","journal-title":"Biotech (Basel)"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0451-9","article-title":"The influence of the microbiome on respiratory health","volume":"20","author":"Wypych","year":"2019","journal-title":"Nat Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.11.008","article-title":"Early-life upper airway microbiota are associated with decreased lower respiratory tract infections","volume":"155","author":"Zelasko","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00494-19","article-title":"Airway mucus restricts neisseria meningitidis away from nasopharyngeal epithelial cells and protects the mucosa from inflammation","volume":"4","author":"Audry","year":"2019","journal-title":"mSphere"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2014.10.001","article-title":"Genomics of streptococcus salivarius, a major human commensal","volume":"33","author":"Delorme","year":"2015","journal-title":"Infect Genet Evol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1534787","article-title":"Gut microbiota is associated with persistence of longer-term bnt162b2 vaccine immunogenicity","volume":"16","author":"Ng","year":"2025","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01598-21","article-title":"Oral bacteria combined with an intranasal vaccine protect from influenza a virus and sars-cov-2 infection","volume":"12","author":"Nagai","year":"2021","journal-title":"mBio"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01301-x","article-title":"Exacerbation of allergic rhinitis by the commensal bacterium streptococcus salivarius","volume":"8","author":"Miao","year":"2023","journal-title":"Nat Microbiol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv341","article-title":"A bivalent vaccine based on a pb2-knockout influenza virus protects mice from secondary pneumococcal pneumonia","volume":"212","author":"Uraki","year":"2015","journal-title":"J Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00265-5","article-title":"Epicutaneous immunization with modified vaccinia ankara viral vectors generates superior T cell immunity against a respiratory viral challenge","volume":"6","author":"Pan","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-02072-9","article-title":"Robust mucosal sars-cov-2-specific T cells effectively combat covid-19 and establish polyfunctional resident memory in patient lungs","volume":"26","author":"Zhu","year":"2025","journal-title":"Nat Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-022-01002-1","article-title":"Intranasal administration of a recombinant rbd vaccine induces long-term immunity against omicron-included sars-cov-2 variants","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138103","article-title":"Evidence for the sialylation of pila, the pi-2a pilus-associated adhesin of streptococcus agalactiae strain nem316","volume":"10","author":"Morello","year":"2015","journal-title":"PloS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2021.1947176","article-title":"Pneumococcal surface adhesion a protein (Psaa) interacts with human annexin A2 on airway epithelial cells","volume":"12","author":"Hu","year":"2021","journal-title":"Virulence"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.10.006","article-title":"Systems vaccinology","volume":"33","author":"Pulendran","year":"2010","journal-title":"Immunity"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.06.014","article-title":"The impact of the microbiome on immunity to vaccination in humans","volume":"28","author":"de Jong","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (Gdp): A comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1618921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:22:28Z","timestamp":1748928148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1618921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":116,"alternative-id":["10.3389\/fimmu.2025.1618921"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1618921","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"article-number":"1618921"}}